KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Cash (2016 - 2025)

Historic Change in Cash for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $671.0 million.

  • Boston Scientific's Change in Cash rose 13282.78% to $671.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 44244.44%. This contributed to the annual value of $1.5 billion for FY2025, which is 44244.44% up from last year.
  • Latest data reveals that Boston Scientific reported Change in Cash of $671.0 million as of Q4 2025, which was up 13282.78% from $735.0 million recorded in Q3 2025.
  • Boston Scientific's Change in Cash's 5-year high stood at $1.4 billion during Q1 2024, with a 5-year trough of -$2.0 billion in Q4 2024.
  • Its 5-year average for Change in Cash is $7.6 million, with a median of $24.0 million in 2021.
  • In the last 5 years, Boston Scientific's Change in Cash soared by 688888.89% in 2022 and then plummeted by 255454.55% in 2024.
  • Boston Scientific's Change in Cash (Quarter) stood at $9.0 million in 2021, then surged by 6888.89% to $629.0 million in 2022, then crashed by 112.24% to -$77.0 million in 2023, then plummeted by 2554.55% to -$2.0 billion in 2024, then surged by 132.83% to $671.0 million in 2025.
  • Its Change in Cash was $671.0 million in Q4 2025, compared to $735.0 million in Q3 2025 and -$179.0 million in Q2 2025.